8-144511967-C-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_004260.4(RECQL4):​c.3337G>C​(p.Gly1113Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000632 in 1,611,598 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1113A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0029 ( 0 hom., cov: 35)
Exomes 𝑓: 0.00039 ( 4 hom. )

Consequence

RECQL4
NM_004260.4 missense

Scores

11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:9O:1

Conservation

PhyloP100: 0.0940

Publications

6 publications found
Variant links:
Genes affected
RECQL4 (HGNC:9949): (RecQ like helicase 4) The protein encoded by this gene is a DNA helicase that belongs to the RecQ helicase family. DNA helicases unwind double-stranded DNA into single-stranded DNAs and may modulate chromosome segregation. This gene is predominantly expressed in thymus and testis. Mutations in this gene are associated with Rothmund-Thomson, RAPADILINO and Baller-Gerold syndromes. [provided by RefSeq, Jan 2010]
RECQL4 Gene-Disease associations (from GenCC):
  • Baller-Gerold syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
  • Rothmund-Thomson syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Rothmund-Thomson syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • osteosarcoma
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • rapadilino syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0037686229).
BP6
Variant 8-144511967-C-G is Benign according to our data. Variant chr8-144511967-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 135152.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00292 (445/152400) while in subpopulation AFR AF = 0.00988 (411/41602). AF 95% confidence interval is 0.00909. There are 0 homozygotes in GnomAd4. There are 206 alleles in the male GnomAd4 subpopulation. Median coverage is 35. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004260.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RECQL4
NM_004260.4
MANE Select
c.3337G>Cp.Gly1113Arg
missense
Exon 19 of 21NP_004251.4
RECQL4
NM_001413019.1
c.3412G>Cp.Gly1138Arg
missense
Exon 18 of 20NP_001399948.1
RECQL4
NM_001413036.1
c.3337G>Cp.Gly1113Arg
missense
Exon 19 of 21NP_001399965.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RECQL4
ENST00000617875.6
TSL:1 MANE Select
c.3337G>Cp.Gly1113Arg
missense
Exon 19 of 21ENSP00000482313.2
RECQL4
ENST00000621189.4
TSL:1
c.2266G>Cp.Gly756Arg
missense
Exon 18 of 20ENSP00000483145.1
RECQL4
ENST00000531875.2
TSL:5
c.583G>Cp.Gly195Arg
missense
Exon 4 of 6ENSP00000477910.1

Frequencies

GnomAD3 genomes
AF:
0.00289
AC:
440
AN:
152282
Hom.:
0
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.00979
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.000805
AC:
198
AN:
245862
AF XY:
0.000671
show subpopulations
Gnomad AFR exome
AF:
0.00856
Gnomad AMR exome
AF:
0.000990
Gnomad ASJ exome
AF:
0.000503
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000171
Gnomad OTH exome
AF:
0.00134
GnomAD4 exome
AF:
0.000393
AC:
574
AN:
1459198
Hom.:
4
Cov.:
57
AF XY:
0.000361
AC XY:
262
AN XY:
725948
show subpopulations
African (AFR)
AF:
0.00899
AC:
301
AN:
33480
American (AMR)
AF:
0.00105
AC:
47
AN:
44650
Ashkenazi Jewish (ASJ)
AF:
0.000996
AC:
26
AN:
26112
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39680
South Asian (SAS)
AF:
0.000116
AC:
10
AN:
86200
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51302
Middle Eastern (MID)
AF:
0.00243
AC:
14
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000855
AC:
95
AN:
1111682
Other (OTH)
AF:
0.00134
AC:
81
AN:
60326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
35
70
105
140
175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00292
AC:
445
AN:
152400
Hom.:
0
Cov.:
35
AF XY:
0.00276
AC XY:
206
AN XY:
74528
show subpopulations
African (AFR)
AF:
0.00988
AC:
411
AN:
41602
American (AMR)
AF:
0.00131
AC:
20
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68048
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
26
53
79
106
132
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000581
Hom.:
0
Bravo
AF:
0.00307
ESP6500AA
AF:
0.00567
AC:
24
ESP6500EA
AF:
0.000118
AC:
1
ExAC
AF:
0.000924
AC:
111
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000475

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:9Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Feb 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RECQL4: BP4

May 21, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not specified Benign:2Other:1
Jun 01, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 11, 2021
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

Rothmund-Thomson syndrome type 2 Uncertain:1
Dec 22, 2020
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868].

Hereditary cancer-predisposing syndrome Benign:1
Oct 09, 2020
Sema4, Sema4
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

Baller-Gerold syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RECQL4-related disorder Benign:1
Mar 08, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
2.3
DANN
Benign
0.74
DEOGEN2
Benign
0.024
T
FATHMM_MKL
Benign
0.46
N
LIST_S2
Benign
0.37
T
MetaRNN
Benign
0.0038
T
MutationAssessor
Benign
1.5
L
PhyloP100
0.094
PrimateAI
Benign
0.31
T
Sift4G
Benign
0.48
T
Polyphen
0.0020
B
Vest4
0.13
MVP
0.71
GERP RS
3.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.053
gMVP
0.21
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35101495; hg19: chr8-145737350; API